Sorted By:

Relevance


Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Food and Drug Administration to update its regulatory framework for biopharmaceutical communications with health care professionals so that physicians can make informed prescribing decisions.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-august-21-2015

PPA: 2016 in review

PhRMA  |  Blog Post

And while the easy-to-use PPA website and mobile app provide patients a single point of access to 475 public and private assistance programs, patient advocates and community leaders now have a unique opportunity to spread the word on what programs are available.
http://catalyst.phrma.org/ppa-2016-in-review

Physicians Deserve Timely Authoritative Risk Information For Medicines

PhRMA  |  Blog Post

PhRMA believes that FDA’s regulation of medical communications – especially important safety information – should ensure that healthcare professionals benefit from scientifically accurate, data-driven information from all sources, including the companies that research and develop new medicines.
http://catalyst.phrma.org/physicians-deserve-timely-authoritative-risk-information-for-medicines

ICYMI: The Wall Street Journal Makes the Case for Sharing Truthful, Non-Misleading Information

PhRMA  |  Blog Post

These judicial rulings should compel the FDA to update its regulatory framework for biopharmaceutical company communications with healthcare professionals.
http://catalyst.phrma.org/icymi-the-wall-street-journal-makes-the-case-for-sharing-truthful-non-misleading-information

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Health Care Policy Developments: Learn about recent legislative and legal action that seeks to improve both patient care and the efficiency of the US healthcare system here.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-august-7-2015

How New Drugs Helping Millions Of Americans Live Longer Are Also Making Them Go Broke

Access Better Coverage  |  From Our Network

“What we’re seeing in the marketplace is that insurers are requiring patients to pay an ever-growing share of their medicine costs,” says Robert Zirkelbach, a senior VP of communications at PhRMA, a trade group that represents the pharmaceutical industry.
http://www.accessbettercoverage.org/social-news/how-new-drugs-helping-millions-of-americans-live-longer-are-also-making-them-go-broke

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post

Helping Patients in Time of Need:   Following Hurricane Katrina, the biopharmaceutical industry and the non-profit sector launched Rx Response – a program designed to streamline communication and tackle medicine delivery problems without delay.
http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-october-2-2015

PhRMA Statement on Presidential Commission on the Opioid Abuse Epidemic

PhRMA  |  Press Release

This public health crisis resulting from abuse of heroin and prescription opioids is complex and far-reaching, impacting communities and families around the country.
https://www.phrma.org/press-release/phrma-statement-on-presidential-commission-on-the-opioid-abuse-epidemic

How innovative medicines are benefiting countries across the globe

PhRMA  |  Blog Post

Advances in treatment are tacking some of the world’s greatest public health challenges.
http://catalyst.phrma.org/how-innovative-medicines-are-benefiting-countries-across-the-globe

How to get value assessment frameworks right

PhRMA  |  Blog Post

Support patient-centered care by considering patient preferences and heterogeneity, appropriately communicating results and avoiding misuse.
http://catalyst.phrma.org/how-to-get-value-assessment-frameworks-right

CSC Survey Finds Discrepancy in Definition of Value in Cancer Care

PhRMA  |  Blog Post

According to the patient, value is defined as “information and appropriate communication of that information at the right time and right place.
http://catalyst.phrma.org/csc-survey-finds-discrepancy-in-definition-of-value-in-cancer-care

Examining the brain in The New Era of Medicine

PhRMA  |  Blog Post

In order to jumpstart a dialogue on the many complex issues impacting the brain – from the diseases which affect it to the social dynamics that influence it – PhRMA is bringing together industry thought leaders, researchers and scientists in Los Angeles for a conversation titled “The Brain: The Next Frontier.” 
http://catalyst.phrma.org/examining-the-brain-in-the-new-era-of-medicine

Drug Importation

PhRMA  |  From PhRMA

In 2003, the Medicare Modernization Act gave the Secretary of Health and Human Services the power to allow the importation of drugs from Canada, if the Secretary could certify the imports would both 1) pose no additional risk to public health and safety, and 2) generate cost-savings  for American consumers.
https://www.phrma.org/advocacy/safety/drug-importation

PhRMA Calls for Repeal of the Ensuring Patient Access and Effective Drug Enforcement Act of 2016

PhRMA  |  Press Release

Food and Drug Administration (FDA) on a public-private partnership to bring new non-opioid therapies to market for patients who are in need of appropriate pain medication.
https://www.phrma.org/press-release/phrma-calls-for-repeal-of-the-ensuring-patient-access-and-effective-drug-enforcement-act-of-2016

Adam Gilden Tsai

PhRMA  |  Biography

  Adam Gilden Tsai, MD, MSCE, FACP, is Assistant Professor of Medicine at the University of Colorado and the chair of the Public Affairs Committee in The Obesity Society.
https://www.phrma.org/biography/adam-gilden-tsai

New nonprofit – I-ACT for Children – launches to promote innovative medicines development for young patients in need

PhRMA  |  Blog Post

Called the Institute for Advanced Clinical Trials for Children (I-ACT for Children), this new organization will seek to foster public-private collaboration in finding solutions to barriers to pediatric medicines development as well as improving the pediatric clinical trials process.
http://catalyst.phrma.org/new-nonprofit-i-act-for-children-launched-to-promote-innovative-medicines-development-for-young-patients-in-need

New Policy Solutions for Innovative Treatment Delivery

PhRMA  |  Press Release

Promoting Value-Driven Health Care - Payers face challenges in paying for the value of prescription medicines because regulatory barriers impede open communication by manufacturers, predictability regarding the biopharmaceutical pipeline, and innovative contracting.
https://www.phrma.org/press-release/phrma-releases-new-policy-solutions-for-delivering-innovative-treatments-to-patients

STEM

PhRMA  |  From PhRMA

The U.S. currently faces a growing gap in STEM skills compared to countries such as Japan, China, and parts of Europe, which are making substantial public investments in STEM education and other key areas of competitiveness, including growing their R&D, manufacturing, and other infrastructure investments.
https://www.phrma.org/media/stem-growing-our-next-generation-of-innovators

Guest Post: Spotlighting the heroes in clinical trials

PhRMA  |  Blog Post

One way we are realizing this goal is by raising awareness of clinical research amongst the general public.
http://catalyst.phrma.org/guest-post-spotlighting-the-heroes-in-clinical-trials

As U.S. looks to modernize NAFTA, strong enforcement of existing obligations should be a top priority

PhRMA  |  Blog Post

Despite the fact that NAFTA and other agreements require CBI—including biopharmaceutical clinical trial and other data—to be protected against disclosure, except where “necessary to protect the public,” Canada has lowered this objective threshold—flying in the face on their international obligations.
http://catalyst.phrma.org/as-u.s.-looks-to-modernize-nafta-strong-enforcement-of-existing-obligations-should-be-a-top-priority

What “value” means to me

PhRMA  |  Blog Post

It’s March, which means it is National Kidney Month.
http://catalyst.phrma.org/what-value-means-to-me

The Pacira Case Study: Patients are better served when health care professionals have the most accurate and up-to-date medical information

PhRMA  |  Blog Post

Unfortunately, despite recent court rulings in the Caronia and Amarin cases explicitly allowing biopharmaceutical companies to provide truthful and non-misleading communications to health care professionals, the FDA continues to muddy the waters with inconsistent actions.
http://catalyst.phrma.org/the-pacira-case-study-patients-are-better-served-when-health-care-professionals-have-the-most-accurate-and-up-to-date-medical-information

Increases in US Life Expectancy

Chartpack  |  From Our Network

"While nutrition, sanitation, other public health measures, and expanded access to care have been major sources of increasing human health, innovative medicines have also played a profound role in this progress.
http://chartpack.phrma.org/biophrma-chartpack/advances-in-treatment/increases-in-us-life-expectancy

New Reports Highlight Increasing Global Competition in Biopharmaceutical R&D, Posing Significant Challenges to Future U.S. Standing

PhRMA  |  Press Release

“Yet, these advances and breakthroughs are only possible through continued support of public policies that promote a highly-skilled, diverse American workforce; support a science-based regulatory system; and ensure a level-playing field with robust trade policies and intellectual property protections.” 
https://www.phrma.org/press-release/new-reports-highlight-increasing-global-competition-in-biopharmaceutical-randd-posing-significant-challenges-to-future-u-s-standing

Coming soon: Clinical Trials Awareness Week, May 2-6

PhRMA  |  Blog Post

clinical trials video, which provides an overview of how the process works and the steps involved; and Read PhRMA’s Q&A with Danielle Lavieri, communications and outreach coordinator for the Center for Information & Study on Clinical Research Participation, to find out if a clinical trial may be right for you.
http://catalyst.phrma.org/coming-soon-clinical-trials-awareness-week-may-2-6

You have reviewed the first 325 results out of 882. Each page contains 25 results. You're on page 13.

prev 13 14 15 16 17 18 next